查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球心臟导管市场-2022-2029
市场调查报告书
商品编码
1146403

全球心臟导管市场-2022-2029

Global Cardiac Catheters Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

心导管市场规模预计将在 2021 年达到 129.5 亿美元，在 2029 年达到 7.028 亿美元，在预测期间（2022-2029 年）以 7.48% 的复合年增长率增长。

心臟导管是用于分析心臟瓣膜以及引导和可视化冠状动脉的仪器。该产品是一种细而柔韧的管子，用于在血管成形术和支架植入等心血管手术期间将设备引导到人体血管中。心导管插入术的需求量很大，因为它比开放手术提供的侵入性更小。

市场动态

由于心臟病患病率增加、生活方式改变和饮食失调以及过度饮酒和吸烟带来的心血管问题，全球心导管插入术市场正在快速增长。 .为此，也出现了动脉阻塞、中风等需要手术治疗的疾病。

心血管疾病患病率上升推动市场增长

血管成形术被推荐用于治疗周围血管疾病。在此过程中，使用心臟导管探查受影响的动脉并使其重新通畅，以使动脉壁中的阻塞变平。根据美国心臟协会的一项研究，到 2020 年，将有 9210 万美国人患有某种形式的 CVD，这使得 CVD 成为美国的头号死因，而不是癌症和其他慢性疾病。

在世界发展中国家，老年人口的增加是主要问题之一。此外，预计在预期的时期内，老年人慢性病的患病率将会增加，例如主动脉疾病、静脉血栓栓塞和外周动脉疾病。根据美国疾病控制和预防中心的数据，到 2020 年，全球 55 至 65 岁的人口中将有超过 19.1% 的人患有外周血管疾病，据推测约有 27% 的男性和超过 21% 的女性会受到影响。老年人最集中的地区是亚太地区，而且这一数字正以历史最高水平增长。

手术和导管的高成本预计将阻碍市场增长

先进导管的高成本可能会限制行业的扩张。越来越多的患者接受导管插入术，患有慢性和心血管疾病，如尿失禁、肾衰竭和冠心病，需要创新导管。然而，这些情况下导管手术的高成本可能会降低低收入国家的导管穿透率。

此外，导管和必要配件的高成本可能会阻碍市场扩张。在收入水平相对较低的不发达国家，导管插入术的高成本可能会限制市场增长。因此，中低收入国家可能很难推出如此昂贵的产品。因此，这些先进设备的高价格可能会在估计数年内抑制导管市场的扩张。

COVID-19 影响分析

COVID-19 疫情将对全球导管行业的增长产生短期负面影响，因为治疗、诊断和手术等服务被暂停以阻止 COVID-19 疾病的传播。预计。据国家医学图书馆称，约旦已实施了与 COVID-19 相关的严格封锁措施。心血管导管插入术干预量在严格封锁期间急剧下降，在部分放鬆封锁后逐渐增加。然而，随着政府和医疗机构加强对 COVID-19 患者的医疗护理，预计医院使用导管的频率将会增加。导管被用于治疗确诊为 COVID-19 的患者。

全球心臟导管市场 - 行业分析

全球心臟导管市场提供基于波特五力、监管分析、供应链分析和定价分析、报销政策、技术进步和 PEST 分析等各种行业因素的市场深入分析。

细分分析

在全球心臟导管市场中，PTA 球囊导管部分预计将占据最大的市场份额

经皮腔内血管成形术称为 PTA。用于微创导管治疗的 PTA 球囊导管在尖端配备了一个可充气的“球囊”。这种方法扩大了狭窄血管的入口。将放气的球囊插入狭窄处，短暂充气，然后再次放气并取出。 PTA 球囊的大小、长度和形状取决于所用血管的解剖结构。使用 PTA 球囊导管治疗外周血管病变有两种方法。一种方法是打开阻塞血管的内腔。这个过程被称为“普通旧球囊血管成形术”（POBA）。另一种方法是扩张支架来治疗阻塞的血管。

此外，PTA 球囊导管产量的增加和 FDA 产品批准的增加预计将刺激全球市场的扩张。例如，美国 FDA 于 2018 年 4 月批准了由 Medtronic Inc. 製造的 PACT Admiral Paclitaxel 涂层经皮腔内血管成形术 (PTA) 球囊导管。

按地区分析

北美在全球心导管市场占有最大的市场份额

2021 年，北美主导了全球心导管插入术市场。这一巨大的收入份额主要是由于泌尿系统疾病、肾衰竭的患病率上升以及高素质外科医生的数量不断增加。例如，美国疾病控制和预防中心 (CDC) 估计，美国每 7 名成年人中就有 1 人或超过 3700 万人患有慢性肾病。预计此类疾病的增加将增加对使用这些设备的导管插入术的需求。美国泌尿外科协会 (AUANET) 估计，2020 年美国将有 13,352 名全职泌尿科医生。此外，心导管术住院患者人数的增加有望带动国内市场的扩大。例如，NCBI 估计美国每年进行超过 100 万次心导管插入术。此外，大公司的扩张将增加消费者需求和产品采用率。因此，由于上述原因，预计对导管治疗的需求将会增加。

竞争格局

心导管市场是一个竞争激烈的市场，行业参与者纷纷进入市场。对全球市场增长做出贡献的主要心导管术厂商有 Becton Dickinson & Company、波士顿科学公司、Bardo Medical、B. Braun Melsungen AG、Teleflex Corporation、强生公司、美敦力公司、Edwards Lifesciences Ltd.、Vascular Solutions, Inc ., 和雅培实验室。领先公司正在为全球心导管市场的增长采用新产品开发和扩张战略。例如，强生医疗器械公司于 2020 年 8 月 13 日宣布，Biosense Webster 的 QDot Micro 射频消融导管已获得欧洲 CE 标誌的批准。

全球心导管市场 - 值得关注的主要参与者

美敦力PLC

概述 Medtronic 是一家製造和销售医疗设备的美国公司，在美国开展业务，总部位于美国明尼阿波利斯。它在大约 140 个国家开展业务，拥有 90,000 名员工。

产品组合 Export Advance 抽吸导管在最重要的时候提供一致的高性能抽吸，恢復血流并保护患者。

本研究报告为全球心导管插入术市场提供大约 45 多个市场数据表、40 多个图和 180 页的组成。

内容

第 1 章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品类型划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 促进因素
      • 心臟病和老年人口的增加
      • 增加研发和高投入
      • 监管批准数量增加
      • 提高医疗保健意识
      • 优惠的保险报销政策
    • 抑制因素
      • 高昂的手术费用和导管费用
      • 导管相关副作用
      • 缺乏熟练的专业人员
  • 影响分析

第 5 章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析
  • 定价分析
  • 保险报销分析
  • 未满足的需求分析

第 6 章按产品类型

  • 电生理导管
  • PTCA 球囊导管
  • IVUS 导管
  • PTA 球囊导管
  • 其他

第 7 章按应用程序

  • 冠状动脉成形术
  • 球囊切开术
  • 导管消融
  • 双极起搏
  • 左心/右心导管术
  • 其他

第 8 章最终用户

  • 医院
  • 门诊手术中心
  • 诊所

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 竞争场景
  • 按产品类型进行的投资组合比较分析
  • 市场定位/市场份额分析
  • 併购分析

第 11 章公司简介

  • Abbott Laboratories
    • 公司简介
    • 按产品类型划分的产品组合和内容
    • 主要亮点
    • 财务摘要
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Bard Medical
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • Johnson & Johnson
  • Medtronic, Inc.
  • Edwards Lifesciences Corp.
  • Vascular Solutions, Inc.

第 12 章全球心臟导管市场-DataM

简介目录
Product Code: DMMD1452

Market Overview

Cardiac Catheters Market size was valued US$ 12.95 billion in 2021 and is estimated to reach US$ 702.8 million by 2029, growing at a CAGR of 7.48% during the forecast period (2022-2029).

Cardiac catheters are instruments used for heart valve analysis or for directing and visualizing the coronary arteries. The product is a thin, flexible tube that is used to guide equipment through the body's blood vessels during cardiovascular treatments like angioplasty and stenting. Since they offer a less invasive interventional method than open surgery, cardiac catheters are in high demand.

Market Dynamics

The global cardiac catheters market is growing due to an increase in the prevalence of heart ailments, cardiovascular issues brought on by altered lifestyle patterns, poor dietary practices, and excessive alcohol and tobacco use, the market for cardiac catheters is growing at a rapid rate. This has further resulted in artery obstruction and stroke, both of which necessitate surgery.

Rising prevalence of cardiovascular diseases drives the growth of the market

For the treatment of peripheral vascular disorders, angioplasty is advised. During this operation, the afflicted artery is examined using a cardiac catheter, which reopens the artery and flattens the blockage in the artery wall. In contrast to cancer and other chronic diseases, the American Heart Association research estimates that 92.1 million Americans were living with some type of CVD in 2020 and that CVD is the leading cause of death in the nation.

One of the main issues in developing nations worldwide is the growing senior population. Additionally, an expected period of time would see a growth in the prevalence of chronic diseases in geriatric individuals, including aortic disease, venous thromboembolism, peripheral arterial disease, etc. In 2020, more than 19.1% of the world's population of seniors aged 55 to 65 had peripheral vascular disease, with about 27% of men and more than 21% of women affected, according to a report from the Centers for Disease Control and Prevention. The largest concentration of senior citizens is in Asia and the Pacific, and their numbers are growing at an unprecedented rate.

The high cost of surgical procedures and catheters is expected to hamper the market growth

The expensive cost of sophisticated catheters could limit industry expansion. A growing proportion of patients undergoing catheterization operations need innovative catheters because they have chronic and cardiovascular disorders like urine bladder, renal failure, and coronary heart disease. However, the adoption rate of catheters may decline throughout low-income countries as a result of the expensive catheterization operations for these disorders.

The expensive price of these gadgets and necessary accessories could limit market expansion. Market growth in underdeveloped nations with relatively low income levels may be constrained because to the high costs involved with catheterization procedures. As a result, it might be challenging for middle-income and low-income countries to adopt such expensive goods. Therefore, the high price of these advanced devices could restrain the expansion of the catheters market over the estimated year.

COVID-19 Impact Analysis

Due to on-hold services, such as treatment, diagnostic, and surgical services, to stop the spread of COVID-19 disease, it is projected that the COVID-19 epidemic will have a short-term negative impact on the growth of the global catheters industry. Jordan implemented a severe COVID-19-related lockout, according to the National Library of Medicine. Cardiovascular catheterization procedure volumes drastically decreased during the rigorous lockdown and gradually increased following a partial relaxation of the lockdown. However, as the government and healthcare organisations continue to enhance medical care for COVID-19 patients, catheters will be utilised more frequently in hospitals. Catheters are being used to treat the patients whose COVID-19 diagnoses were verified.

Global Cardiac Catheters Market - Industry Analysis

The global cardiac catheters market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis, reimbursement policies, technological advancements, PEST analysis.

Segment Analysis

The PTA balloon catheter segment is expected to hold the largest market share in global cardiac catheters market

Percutaneous transluminal angioplasty is referred to as PTA. The PTA balloon catheter, used in a minimally invasive catheterization treatment, includes an inflatable "balloon" at its tip. The narrowed vascular entrance is widened with this method. The deflated balloon is placed in the constricted area, briefly inflated, and then deflated once more for removal. The anatomy that PTA balloons are designed to treat determines the many sizes, lengths, and shapes that are available. Peripheral vascular lesions can be treated with PTA balloon catheters in two different ways. One method is to widen the lumen of a blood artery that is blocked. This procedure is known as "plain-old balloon angioplasty" (POBA). The second application is for treating vascular blockages by expanding stents.

Additionally, it is anticipated that rising PTA balloon catheter production and rising FDA product approvals will fuel the expansion of the global market. For instance, the U.S. FDA approved the PACT Admiral Paclitaxel coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter manufactured by Medtronic Inc. in April 2018.

Geographical Analysis

North America region holds the largest market share in the global cardiac catheters market

North America was held a dominant position in the global cardiac catheters market in 2021. This large revenue share is mainly due to the rising prevalence of urological illnesses, renal failure, and the abundance of highly qualified surgeons, among other things. For instance, every seventh adult in the United States, or more than 37 million people, is projected to have chronic kidney disease, according to estimates from the Centers for Disease Control and Prevention (CDC). It is anticipated that the rising prevalence of diseases would increase the demand for catheterization operations, which employ these devices. The American Urological Association (AUANET) estimates that there will be 13,352 urologists working full-time in the United States in 2020. Additionally, it is anticipated that rising cardiac catheterization hospitalizations will promote market expansion in the nation. For instance, the NCBI estimates that more than 1,000,000 cardiac catheterization operations are carried out each year in the United States. Major players' presence in the area will also increase consumer demand and adoption rates for the products. Therefore, it is anticipated that the aforementioned causes will increase demand for catheterization procedures.

Competitive Landscape

The cardiac catheters market is highly competitive, owing to big market players in the industry. The key cardiac catheters players which are contributing to the growth of the global market include Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic Plc, Edwards Lifesciences Corp, Vascular Solutions, Inc, Abbott Laboratories. The major players are adopting new product development and expansion strategies for global growth in the cardiac catheters market. For instance, Johnson & Johnson Medical Devices announced on August 13, 2020, that the QDot Micro radiofrequency ablation catheter from Biosense Webster has been granted European CE mark approval.

Global Cardiac catheters Market - Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio: Export Advance aspiration catheter delivers consistent, high-performing aspiration power when it matters most restoring flow and protecting patients.

The global cardiac catheters market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-user
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the prevalence of cardiac diseases and geriatric population
      • 4.1.1.2. Increase in R&D and high investments
      • 4.1.1.3. The increasing number of regulatory approvals
      • 4.1.1.4. Increasing awareness of healthcare
      • 4.1.1.5. Favorable reimbursement policies
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost of surgical procedures and catheters
      • 4.1.2.2. The side effects associated with catheters
      • 4.1.2.3. Lack of skilled professionals
  • 4.2. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. By Product type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
  • 6.3. Market Attractiveness Index, By Product type
    • 6.3.1. Electrophysiology Catheters *
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2019-2026
    • 6.3.2. PTCA Balloons Catheters
    • 6.3.3. IVUS Catheters
    • 6.3.4. PTA Balloons Catheters
    • 6.3.5. Others

7. By Application

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 7.3. Market Attractiveness Index, By Application
    • 7.3.1. Coronary angioplasty *
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2019-2026
    • 7.3.2. Balloon septostomy
    • 7.3.3. Catheter ablation
    • 7.3.4. Bipolar pacing
    • 7.3.5. left/right heart catheterization
    • 7.3.6. others

8. By End-user

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  • 8.3. Market Attractiveness Index, By End-user
    • 8.3.1. Hospitals *
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2019-2026
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Clinics

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. U.S.
      • 9.4.6.2. Canada
      • 9.4.6.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. Germany
      • 9.5.6.2. U.K.
      • 9.5.6.3. France
      • 9.5.6.4. Italy
      • 9.5.6.5. Spain
      • 9.5.6.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.6.7. Brazil
    • 9.6.8. Argentina
    • 9.6.9. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.6.1. China
      • 9.7.6.2. India
      • 9.7.6.3. Japan
      • 9.7.6.4. Australia
      • 9.7.6.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Comparative Product type Portfolio Analysis
  • 10.3. Market Positioning/Share Analysis
  • 10.4. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Abbott Laboratories*
    • 11.1.1. Company Overview
    • 11.1.2. Product type Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Becton Dickinson and Company
  • 11.3. Boston Scientific Corporation
  • 11.4. Bard Medical
  • 11.5. B. Braun Melsungen AG
  • 11.6. Teleflex Incorporated
  • 11.7. Johnson & Johnson
  • 11.8. Medtronic, Inc.
  • 11.9. Edwards Lifesciences Corp.
  • 11.10. Vascular Solutions, Inc.

LIST NOT EXHAUSTIVE

12. Global Cardiac Catheters Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us